<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Standard Automated Perimetry - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjYAe1fdyHj2Y9gmtVIAAAAB4","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Standard_Automated_Perimetry","wgTitle":"Standard Automated Perimetry","wgCurRevisionId":87693,"wgRevisionId":87693,"wgArticleId":593,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Standard_Automated_Perimetry","wgRelevantArticleId":593,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],
"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Visual function assessment is integral to the evaluation and management of glaucoma. Visual field testing can be performed by various methods, including confrontation technique, amsler grid, tangent screen, kinetic perimetry, or static perimetry. This review will focus primarily on standard automated perimetry (SAP). Advances in computer technology have facilitated more sensitive and reproducible visual field loss detection than was possible with manual perimetry, allowing clinicians to detect glaucoma earlier in its course and to monitor loss quantitatively over time."/>
<meta name="date" content="2022-12-24"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Standard Automated Perimetry" href="/w/index.php?title=Special:ExportRDF/Standard_Automated_Perimetry&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Standard_Automated_Perimetry rootpage-Standard_Automated_Perimetry layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Standard+Automated+Perimetry" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Standard+Automated+Perimetry" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzyzz9ng"></button>
					<div class="collapse navbar-collapse hbpzyzz9ng" id="hbpzyzz9ng">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Standard_Automated_Perimetry" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Standard_Automated_Perimetry&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Standard_Automated_Perimetry&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Standard_Automated_Perimetry&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Standard_Automated_Perimetry&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Standard_Automated_Perimetry#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Standard Automated Perimetry</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Pradeep.Y.Ramulu.CMT" title="User:Pradeep.Y.Ramulu.CMT">Pradeep Ramulu, M.D.</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Sarwat.Salim.SEC" title="User:Sarwat.Salim.SEC">Sarwat Salim MD, FACS</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Pradeep.Y.Ramulu.CMT" title="User:Pradeep.Y.Ramulu.CMT">Pradeep Ramulu, M.D.</a>,&#160;<a href="/User:David.Kitchen" title="User:David.Kitchen">David Kitchen</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a> on December 25, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Standard_Automated_Perimetry&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Standard_Automated_Perimetry&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Summary"><span class="tocnumber">1</span> <span class="toctext">Summary</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#The_field_of_vision"><span class="tocnumber">2</span> <span class="toctext">The field of vision</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Normal_field_of_vision"><span class="tocnumber">2.1</span> <span class="toctext">Normal field of vision</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Cellular_basis_for_the_field_of_vision"><span class="tocnumber">2.2</span> <span class="toctext">Cellular basis for the field of vision</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Retinal_nerve_fiber_paths_and_the_field_of_vision"><span class="tocnumber">2.3</span> <span class="toctext">Retinal nerve fiber paths and the field of vision</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Characteristics_of_visual_field_loss_in_glaucoma"><span class="tocnumber">2.4</span> <span class="toctext">Characteristics of visual field loss in glaucoma</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Perimetric_Parameters"><span class="tocnumber">3</span> <span class="toctext">Perimetric Parameters</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Manual_vs._Automated_Perimetry"><span class="tocnumber">3.1</span> <span class="toctext">Manual vs. Automated Perimetry</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Static_vs._Dynamic_Perimetry"><span class="tocnumber">3.2</span> <span class="toctext">Static vs. Dynamic Perimetry</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Target_size_and_luminance"><span class="tocnumber">3.3</span> <span class="toctext">Target size and luminance</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Testing_Algorithms"><span class="tocnumber">3.4</span> <span class="toctext">Testing Algorithms</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#Full_threshold_strategy_.28FT.29"><span class="tocnumber">3.4.1</span> <span class="toctext">Full threshold strategy (FT)</span></a></li>
<li class="toclevel-3 tocsection-13"><a href="#FASTPAC"><span class="tocnumber">3.4.2</span> <span class="toctext">FASTPAC</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Swedish_Interactive_Threshold_Algorithm_.28SITA.29"><span class="tocnumber">3.4.3</span> <span class="toctext">Swedish Interactive Threshold Algorithm (SITA)</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-15"><a href="#Monitoring_Fixation"><span class="tocnumber">3.5</span> <span class="toctext">Monitoring Fixation</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Monocular_vs._Binocular_testing"><span class="tocnumber">3.6</span> <span class="toctext">Monocular vs. Binocular testing</span></a></li>
<li class="toclevel-2 tocsection-17"><a href="#Alternative_perimetric_targets"><span class="tocnumber">3.7</span> <span class="toctext">Alternative perimetric targets</span></a>
<ul>
<li class="toclevel-3 tocsection-18"><a href="#Short-wavelength_automated_perimetry_.28SWAP.29"><span class="tocnumber">3.7.1</span> <span class="toctext">Short-wavelength automated perimetry (SWAP)</span></a></li>
<li class="toclevel-3 tocsection-19"><a href="#Frequency_doubling_technology_.28FDT.29"><span class="tocnumber">3.7.2</span> <span class="toctext">Frequency doubling technology (FDT)</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#Interpretation_of_SAP"><span class="tocnumber">4</span> <span class="toctext">Interpretation of SAP</span></a>
<ul>
<li class="toclevel-2 tocsection-21"><a href="#Display"><span class="tocnumber">4.1</span> <span class="toctext">Display</span></a>
<ul>
<li class="toclevel-3 tocsection-22"><a href="#Patient_and_Test_details"><span class="tocnumber">4.1.1</span> <span class="toctext">Patient and Test details</span></a></li>
<li class="toclevel-3 tocsection-23"><a href="#Displays_of_sensitivities_across_the_visual_field"><span class="tocnumber">4.1.2</span> <span class="toctext">Displays of sensitivities across the visual field</span></a></li>
<li class="toclevel-3 tocsection-24"><a href="#Summary_measures_of_visual_field_performance"><span class="tocnumber">4.1.3</span> <span class="toctext">Summary measures of visual field performance</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-25"><a href="#Establishing_reliability_of_results"><span class="tocnumber">4.2</span> <span class="toctext">Establishing reliability of results</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Identifying_Glaucomatous_VF_Loss_on_SAP"><span class="tocnumber">4.3</span> <span class="toctext">Identifying Glaucomatous VF Loss on SAP</span></a>
<ul>
<li class="toclevel-3 tocsection-27"><a href="#Mean_deviation"><span class="tocnumber">4.3.1</span> <span class="toctext">Mean deviation</span></a></li>
<li class="toclevel-3 tocsection-28"><a href="#Pattern_Standard_Deviation"><span class="tocnumber">4.3.2</span> <span class="toctext">Pattern Standard Deviation</span></a></li>
<li class="toclevel-3 tocsection-29"><a href="#Glaucoma_Hemifield_Test_.28GHT.29"><span class="tocnumber">4.3.3</span> <span class="toctext">Glaucoma Hemifield Test (GHT)</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-30"><a href="#Common_perimetric_errors"><span class="tocnumber">4.4</span> <span class="toctext">Common perimetric errors</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-31"><a href="#Additional_Resources"><span class="tocnumber">5</span> <span class="toctext">Additional Resources</span></a></li>
<li class="toclevel-1 tocsection-32"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Summary">Summary</span></h1>
<p>Visual function assessment is integral to the evaluation and management of glaucoma. Visual field testing can be performed by various methods, including confrontation technique, amsler grid, tangent screen, kinetic perimetry, or static perimetry. This review will focus primarily on standard automated perimetry (SAP). Advances in computer technology have facilitated more sensitive and reproducible visual field loss detection than was possible with manual perimetry, allowing clinicians to detect glaucoma earlier in its course and to monitor loss quantitatively over time. 
</p>
<h1><span class="mw-headline" id="The_field_of_vision">The field of vision</span></h1>
<h2><span class="mw-headline" id="Normal_field_of_vision">Normal field of vision</span></h2>
<p>The normal eye can detect stimuli over a 120º range vertically and a nearly 160 degree range horizontally. From the point of fixation, stimuli can typically be detected 60º superiorly, 70º inferiorly, 60º nasally, and 100 degrees temporally,<sup id="cite_ref-Anderson1998_1-0" class="reference"><a href="#cite_note-Anderson1998-1">&#91;1&#93;</a></sup> though the true extent of the visual field depends on several features of the stimulus (size, brightness, motion) as well as the background conditions. The field of vision is often depicted as a three dimensional hill, with the peak sensitivity to stimuli occurring at the point of fixation under photopic conditions, decreasing rapidly in the 10º around fixation, and then decreasing very gradually for locations further in the periphery.<sup id="cite_ref-Hart1983_2-0" class="reference"><a href="#cite_note-Hart1983-2">&#91;2&#93;</a></sup> Nerve fibers pass through the sclera at the optic nerve head, typically 10-15º nasal to fixation. At this location, no photoreceptors are present, creating a normal absolute scotoma.<sup id="cite_ref-Armaly1969_3-0" class="reference"><a href="#cite_note-Armaly1969-3">&#91;3&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Cellular_basis_for_the_field_of_vision">Cellular basis for the field of vision</span></h2>
<p>Detection of visual stimuli relies on an intact neural pathway beginning with retinal photoreceptors, and then proceeding through bipolar cells, retinal ganglion cells (RGC), and brain neurons extending from the lateral geniculate to the occipital cortex. Visual field loss in glaucoma is the result of damage to the RGCs. Bipolar cells synapse with several different types of RGCs, and it is believed that each type of RGC completely covers the field of vision. Some RGC types may be more damaged in glaucoma&#160;than other types, leading to the idea that visual stimuli preferentially detected by RGC types which are most likely to be damaged in glaucoma would be able to detect glaucoma at its earliest stages. The three types of ganglion cells are parvocellular, magnocellular, and koniocellular.&#160; Of these, the parvocellular or p cells are the&#160;most abundant and transmit information about color and form. The magnocellular cells transmit information about flicker and motion. The koniocellular cells are&#160; involved with transmission of short or blue wavelength.&#160; This redundancy in ganglion cells is responsible for non-selective nature of standard automated perimetry (SAP),&#160;and histological studies have shown that a significant number of ganglion cells may be lost before visual field deficits are manifested on SAP.<sup id="cite_ref-Kerrigan2000_4-0" class="reference"><a href="#cite_note-Kerrigan2000-4">&#91;4&#93;</a></sup> This rationale has led to development of new perimetric tests such as short-wavelength automated perimetry (SWAP) and frequency doubling technology (FDT), which may be able to enhance earlier detection of functional loss by targeting a specific subset of ganglion cells that have sparse distribution. Both SWAP and FDT are described in more details later. 
</p>
<h2><span class="mw-headline" id="Retinal_nerve_fiber_paths_and_the_field_of_vision">Retinal nerve fiber paths and the field of vision</span></h2>
<p>Axons extending toward the optic nerve head from the RGCs for the retinal nerve fiber layer (rNFL). The rNFL responsible for providing the superior and inferior hemifield of vision can be divided into 3 divisions: 
</p>
<ol><li>Nasal fiber supporting the retina nasal to the optic nerve head.</li>
<li>The maculopapillary bundle proceeding directly from the macula to the temporal optic nerve head.</li>
<li>The arcuate fibers. These fibers are names for the arcuate course they take from the peripheral macula and the temporal retina outside the macula to the superior and inferior optic nerve head.</li></ol>
<h2><span class="mw-headline" id="Characteristics_of_visual_field_loss_in_glaucoma">Characteristics of visual field loss in glaucoma</span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:CentralIsland.jpg" class="image"><img alt="CentralIsland.jpg" src="/w/images/1/thumb/9/95/CentralIsland.jpg/300px-CentralIsland.jpg" decoding="async" width="300" height="241" class="thumbimage" srcset="/w/images/1/thumb/9/95/CentralIsland.jpg/450px-CentralIsland.jpg 1.5x, /w/images/1/thumb/9/95/CentralIsland.jpg/600px-CentralIsland.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:CentralIsland.jpg" class="internal" title="Enlarge"></a></div></div></div></div><div class="thumb tleft"><div class="thumbinner" style="width:302px;"><a href="/File:ArcuateInferior.jpg" class="image"><img alt="ArcuateInferior.jpg" src="/w/images/1/thumb/1/19/ArcuateInferior.jpg/300px-ArcuateInferior.jpg" decoding="async" width="300" height="225" class="thumbimage" srcset="/w/images/1/thumb/1/19/ArcuateInferior.jpg/450px-ArcuateInferior.jpg 1.5x, /w/images/1/thumb/1/19/ArcuateInferior.jpg/600px-ArcuateInferior.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:ArcuateInferior.jpg" class="internal" title="Enlarge"></a></div></div></div></div><p>The most common&#160;types of visual field&#160;deficits&#160;in glaucoma result from damage&#160;to the&#160;nerve fibers&#160;in a &#160;given&#160;location and distribution. As nasal fibers and the maculopapular bundle are typically spared until late in the disease process, it is common to have a central or temporal island of vision remaining in eyes with advanced glaucoma Damage to the arcuate fibers, on the other hand, is commonly seen and&#160;deficits correspond to the anatomy of these fibers. Damage is always nasal to the blind spot, and is often in the form of a “step” in the nasal aspect of the visual field.<sup id="cite_ref-Leblanc1971_5-0" class="reference"><a href="#cite_note-Leblanc1971-5">&#91;5&#93;</a></sup><sup id="cite_ref-Werner1979_6-0" class="reference"><a href="#cite_note-Werner1979-6">&#91;6&#93;</a></sup> More significant damage to the arcuate fibers can result in an arcuate or Bjerrum scotoma. Occasionally, RGCs from the inferior parafoveal retina join the arcuate fibers, resulting in&#160;a superior paracentral scotoma. As the arcuate fibers do not cross the horizontal midline, most glaucomatous visual field loss respects (i.e. doesn’t cross) the horizontal midline. Finally, while glaucomatous visual field loss can occur anywhere in the visual field, most patients with visual field loss have some detectable field loss within the central 24-30º.<sup id="cite_ref-Ballon1992_7-0" class="reference"><a href="#cite_note-Ballon1992-7">&#91;7&#93;</a></sup> 
</p><p><b>Photos Courtesy of Pradeep Ramulu, MD, PhD, Wilmer Eye Institute<br /></b>
</p>
<h1><span class="mw-headline" id="Perimetric_Parameters">Perimetric Parameters</span></h1>
<p>Perimetry refers to the systematic measurement of the visual field, and is an essential component of defining the extent and progression of glaucoma, as well as numerous other eye conditions. All perimeters measure sensitivity to stimuli at multiple locations in the visual field, though multiple variables define the perimeter. Currently, standard automated perimetry or white on white perimetry is the most common form of visual field testing. Here, a white stimulus is projected on a white background to determine the threshold values. 
</p>
<h2><span class="mw-headline" id="Manual_vs._Automated_Perimetry">Manual vs. Automated Perimetry</span></h2>
<p>While all perimetric tests require a perimetrist to administer the test, manual perimetry requires a greater interaction between the perimetrist and the subject, most often with regards to manual presentation of the stimulus and recording of the patient’s response to the stimulus. 
</p>
<ul><li>Automated perimetry offers obvious advantages to manual perimetry in that stimulus presentation as well as the recording of patient responses can be standardized, leading to more&#160;reproducible results.</li>
<li>Manual perimetry is still useful for individuals who cannot adapt well to the automated interface. Additionally, manual perimetry is not confined to the visual field testing algorithms defined by automated perimeters, and remains useful for testing in certain situations.</li></ul>
<table class="wikitable">

<tbody><tr>
<th>Advantages of Automated Perimetry
</th></tr>
<tr>
<td>
<ul><li>Provides more sensitive and reproducible results</li>
<li>Provides quantitative information</li>
<li>Provides results in a more timely manner</li>
<li>Experienced perimetrist is not required</li>
<li>With newer perimetric tests, early detection of glaucomatous damage is possible<br /></li></ul>
</td></tr>
</tbody></table>
<h2><span class="mw-headline" id="Static_vs._Dynamic_Perimetry">Static vs. Dynamic Perimetry</span></h2>
<p>Stimuli presented by perimeters can be static or kinetic. 
</p>
<ul><li>In kinetic perimetry, a stimulus is moved from a non-seeing (subthreshold) area to a seeing (suprathreshold) area, and the location where the object is first seen is recorded. The speed the stimulus is moved should be standardized, typically at 2-4 degrees per second.<sup id="cite_ref-Johnson1987_8-0" class="reference"><a href="#cite_note-Johnson1987-8">&#91;8&#93;</a></sup></li>
<li>In static perimetry, stationary stimuli are presented at defined points in the visual field. Stimuli presented for longer durations of time may be seen better as a result of temporal summation of information, though limited additional benefit is derived beyond times over 1/10th of a second.<sup id="cite_ref-Allingham2004_9-0" class="reference"><a href="#cite_note-Allingham2004-9">&#91;9&#93;</a></sup></li></ul>
<p><br />
The Humphrey and Octopus perimeters use stimuli presented for 0.2 seconds and 0.1 seconds, respectively, maximizing temporal summation while minimizing patient attempts to redirect fixation towards the stimulus.<sup id="cite_ref-Greve1973_10-0" class="reference"><a href="#cite_note-Greve1973-10">&#91;10&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Target_size_and_luminance">Target size and luminance</span></h2>
<p>Larger targets are more likely to be detected based on spatial summation of the stimulus.<sup id="cite_ref-Johnson1978_11-0" class="reference"><a href="#cite_note-Johnson1978-11">&#91;11&#93;</a></sup> Target sizes of stimuli used in modern perimeters frequently use the convention introduced with the Goldmann perimetry. Five different stimulus sizes are defined by Roman numerals I through V. Each stimulus covers a 4-fold greater area, ranging from 0.25 mm<sup>2</sup> for a size I stimulus, to 64 mm<sup>2</sup> for a size V stimulus. For the Humphrey perimeter, a test stimulus of 4 mm<sup>2</sup> (corresponding to a Goldmann size III stimulus) is most commonly used, though larger stimulus sizes may be employed for individuals with poor visual acuity. 
</p><p>The Humphrey perimeter tests light intensities over 5 orders of magnitudes, from 10,000 apostilbs (asb) to 0.1 asb. Every log order change in light intensity corresponds to 10 dB, such that the machine can measure sensitivities over a 50 dB range. Test locations unable to see a stimulus of 10,000 asb are assumed to be totally blind (though they may still see brighter lights (or other visual stimuli such as motion), and are assigned a value of 0 dB. The threshold values reported for each location reflect the extent to which light can be dimmed and still detected. For example, a value of 30 dB indicates that the stimulus can be dimmed 1000-fold to 10 asb. 
</p><p>The state of light adaptation of the eye at the time of the visual field test influences luminance sensitivities. The Humphrey perimeter uses background lighting of 31.5 abs to saturate rod photoreceptors, producing photopic conditions in which cones are primarily tested.<sup id="cite_ref-Johnson1981_12-0" class="reference"><a href="#cite_note-Johnson1981-12">&#91;12&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Testing_Algorithms">Testing Algorithms</span></h2>
<p>Visual field tests employ either threshold or suprathreshold algorithms. In suprathreshold tests, an intensity of pre-determined brightness is employed at each test location. Thus, the precise sensitivity of each test location is not known. In threshold testing, an attempt is made to measure the intensity of the dimmest stimulus which can be detected 50% of the time. Several algorithms exist for approximating threshold values: 
</p>
<h3><span id="Full_threshold_strategy_(FT)"></span><span class="mw-headline" id="Full_threshold_strategy_.28FT.29">Full threshold strategy (FT)</span></h3>
<p>In this test strategy, a suprathreshold stimulus is presented at each location based on the threshold values from prior points. Intensity is decreased at fixed increments until the stimulus is no longer seen, and then increased at fixed increments until it is seen again. The threshold value is taken to be equal to the intensity of the last stimulus seen at that location. Compared with newer strategies, full threshold strategies employ smaller steps in intensity and involve more reversals in the direction of presented stimuli (i.e. ascending or descending), resulting in longer test times. 
</p>
<h3><span class="mw-headline" id="FASTPAC">FASTPAC</span></h3>
<p>This program determines threshold with a single reversal using an increment of 3 dB. Although it is faster than FT, it has been reported to underestimate the severity of visual field defects.
</p>
<h3><span id="Swedish_Interactive_Threshold_Algorithm_(SITA)"></span><span class="mw-headline" id="Swedish_Interactive_Threshold_Algorithm_.28SITA.29">Swedish Interactive Threshold Algorithm (SITA)</span></h3>
<p>This algorithm developed for the Humphrey perimeter uses a complex mathematical model to estimate threshold values for each point based on responses to stimuli presented at that location, as well as information gathered from nearby locations.<sup id="cite_ref-Bengtsson1997_13-0" class="reference"><a href="#cite_note-Bengtsson1997-13">&#91;13&#93;</a></sup><sup id="cite_ref-Bengtsson1998_14-0" class="reference"><a href="#cite_note-Bengtsson1998-14">&#91;14&#93;</a></sup>&#160; Full threshold values are still obtained for the first 4 points tested (one in each quadrant of the visual field), and at least one reversal from descending to ascending intensity is obtained for each location. Test times in normal individuals are roughly half as long as full threshold tests, with similar or better reproducibility.<sup id="cite_ref-Shirato1999_15-0" class="reference"><a href="#cite_note-Shirato1999-15">&#91;15&#93;</a></sup><sup id="cite_ref-Sharma2000_16-0" class="reference"><a href="#cite_note-Sharma2000-16">&#91;16&#93;</a></sup><sup id="cite_ref-Sekhar2000_17-0" class="reference"><a href="#cite_note-Sekhar2000-17">&#91;17&#93;</a></sup> 
</p><p>&#160;&#160; 
</p>
<table class="wikitable">
<tbody><tr>
<th>Features of SITA
</th></tr>
<tr>
<td>
<p>Available on both Humphrey Visual Field Analyzer and Octopus 
</p><p>Significantly reduces total testing time without compromising the accuracy and reliability of the data 
</p><p>Available as SITA STANDARD (SS), SITA FAST (SF), and SITA FASTER (SFr) 
</p>
<ul><li>SS takes 7 min per eye</li>
<li>SF takes 4 min per eye</li>
<li>SFr takes 2 min per eye<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">&#91;18&#93;</a></sup></li></ul>
<p><br />
24-2 Program tests 54 points 
</p><p>24-2c Program tests 64 points, including 10 additional macular points 
</p><p>30-2 Program tests 76 points
</p>
</td></tr></tbody></table>
<h2><span class="mw-headline" id="Monitoring_Fixation">Monitoring Fixation</span></h2>
<p>Fixation is typically monitored in visual field testing by one or more of the methods below:
</p>
<ol><li>Testing of the physiological blind spot. Each eye has a physiological blind spot at the optic nerve head, where the absence of photoreceptors produces an absolute scotoma roughly 10-15º temporal to the fovea. Fixation can be tested by mapping of the blind spot, and then retesting the blind spot throughout the visual field test. Positive responses during retesting of the blind spot are assumed to reflect loss of fixation.</li>
<li>Monitoring of eye movements using an eye tracker system. Outputs, however, require an understanding of how much eye movement is normal during a typical visual field test. Additionally, tracking may be unreliable in individuals with abnormal pupils, i.e. after previous surgery.</li>
<li>Manual monitoring of fixation by the perimetrist. While this is the only way to ensure proper fixation in manual perimeters, it is also an important element in automated perimetry. Many visual field systems allow the perimetrist to observe the eyes of the test taker, allowing for instant feedback and instruction&#160;to individuals who do not maintain their gaze on the fixation target.</li></ol>
<h2><span class="mw-headline" id="Monocular_vs._Binocular_testing">Monocular vs. Binocular testing</span></h2>
<p>Most perimetric tests require separate testing of right and left eyes. A few tests, however, have been designed to test the binocular visual field. The Esterman test available on the Humphrey Field Analyzer is a suprathreshold test for bilateral visual field loss.<sup id="cite_ref-Esterman1982_19-0" class="reference"><a href="#cite_note-Esterman1982-19">&#91;19&#93;</a></sup> Points are not evenly spaced, with more points displayed near the horizontal midline. Methods have also been developed to combine the left and right eye visual field results into a simulated integrated visual field. To date, however, no evidence exists that true binocular visual fields or integrated visual fields are more predictive of important negative outcomes such as falls or motor vehicle accidents.<sup id="cite_ref-Ramulu2009_20-0" class="reference"><a href="#cite_note-Ramulu2009-20">&#91;20&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Alternative_perimetric_targets">Alternative perimetric targets</span></h2>
<p>As mentioned previously,&#160;a significant number of ganglion cells may be lost before visual field deficits are manifested on SAP,<sup id="cite_ref-Quigley1988_21-0" class="reference"><a href="#cite_note-Quigley1988-21">&#91;21&#93;</a></sup> making it desirable to find distinct perimetric targets that would identify glaucomatous damage earlier in the disease process. Two specific alternative perimetric targets have been proposed which may target subsets of RGCs preferentially damaged in early glaucoma:<sup><sup id="cite_ref-Johnson1993_22-0" class="reference"><a href="#cite_note-Johnson1993-22">&#91;22&#93;</a></sup><sup id="cite_ref-Johnson1997_23-0" class="reference"><a href="#cite_note-Johnson1997-23">&#91;23&#93;</a></sup></sup> 
</p>
<h3><span id="Short-wavelength_automated_perimetry_(SWAP)"></span><span class="mw-headline" id="Short-wavelength_automated_perimetry_.28SWAP.29">Short-wavelength automated perimetry (SWAP)</span></h3>
<p>SWAP utilizes the koniocellular pathway and selectively measures the short blue wavelength function by projecting a blue stimulus on a yellow background.16 SWAP has been found to identify early glaucomatous damage in ocular hypertensives, glaucoma suspects, and patients with glaucoma. SWAP may detect visual defects up to five years earlier than SAP in some patients.<sup id="cite_ref-Demirel2001_24-0" class="reference"><a href="#cite_note-Demirel2001-24">&#91;24&#93;</a></sup><sup id="cite_ref-Johnson1993_22-1" class="reference"><a href="#cite_note-Johnson1993-22">&#91;22&#93;</a></sup> Despite its improved sensitivity in the assessment of functional deficits in glaucoma, SWAP has several limitations. It demonstrates higher test-retest variability than SAP and is influenced by media opacities. In addition, the prolonged testing time makes it less acceptable by the patients and less efficient in the practice. When interpreting results obtained with SWAP, emphasis should be placed on parameters less affected by generalized reduction, such as glaucoma hemifield test and pattern threshold deviation plot. SWAP is available on HFA II series and Octopus 1-2-3 perimeters. Recently, SITA SWAP has been introduced on 24-2 program and has demonstrated significant reduction in both testing time and variability.
</p>
<h3><span id="Frequency_doubling_technology_(FDT)"></span><span class="mw-headline" id="Frequency_doubling_technology_.28FDT.29">Frequency doubling technology (FDT)</span></h3>
<p>FDT is based on the concept that a combination of low spatial frequency and high temporal frequency preferentially targets ganglion cells of the magnocellular pathway.<sup id="cite_ref-Anderson2003_25-0" class="reference"><a href="#cite_note-Anderson2003-25">&#91;25&#93;</a></sup><sup></sup>Due to selective uncovering of functional deficits in the My ganglion cells, FDT has been shown to have high sensitivity and specificity for early detection of glaucoma.<sup id="cite_ref-Cioffi2000_26-0" class="reference"><a href="#cite_note-Cioffi2000-26">&#91;26&#93;</a></sup><sup id="cite_ref-Spry2001_27-0" class="reference"><a href="#cite_note-Spry2001-27">&#91;27&#93;</a></sup> In addition, given its low test-retest variability compared to SAP, FDT may be advantageous in monitoring progressive loss. Both threshold and screening tests can be performed with FDT, taking approximately five minutes and one minute, respectively. The two threshold layouts are denoted C-20 and N-30 and measure 17 and 19 target locations, respectively. Until recently, a major concern has centered on a large stimulus size used in FDT. FDT can now be performed with a matrix of smaller points, allowing better quantification of defects and increasing its capability to follow progression. <br />
</p>
<h1><span class="mw-headline" id="Interpretation_of_SAP">Interpretation of SAP</span></h1>
<h2><span class="mw-headline" id="Display">Display</span></h2>
<p>The results displayed from visual field testing are divided into 3 sections:<br />
</p>
<h4><span class="mw-headline" id="Patient_and_Test_details">Patient and Test details</span></h4><p>
These details are typically displayed on the top of the printout, and includes the following information:</p><div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:VFDisplay.jpg" class="image"><img alt="VFDisplay.jpg" src="/w/images/1/thumb/1/12/VFDisplay.jpg/300px-VFDisplay.jpg" decoding="async" width="300" height="87" class="thumbimage" srcset="/w/images/1/thumb/1/12/VFDisplay.jpg/450px-VFDisplay.jpg 1.5x, /w/images/1/thumb/1/12/VFDisplay.jpg/600px-VFDisplay.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:VFDisplay.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<ol><li>Patient's name, date of birth, and age at the time of the test.</li>
<li>Date and time of the test.</li>
<li>Refractive error correction used during test.</li>
<li>Type of test performed, including the type of stimulus used, the background light level, and the testing strategy employed.</li>
<li>Details on the method of fixation monitoring.</li>
<li>Information to help judge the reliability of the test, including the rate of fixation losses, false positive errors, false negative errors, and the time necessary for testing.</li></ol>
<h4><span class="mw-headline" id="Displays_of_sensitivities_across_the_visual_field">Displays of sensitivities across the visual field</span></h4>
<p>This information is shown in multiple different ways:
</p>
<ol><li>A numerical plot gives the threshold for all points checked</li>
<li>A grey scale plot graphically demonstrates regions to visual field loss by displaying regions with decreased sensitivity in darker tones. Areas of abnormally high sensitivity are shown as white.</li>
<li>Total deviation plot. This plot shows the deviation of the patient’s result from that of age-matched controls at each test location. Each test location is graded as normal, or abnormal at a defined level (p value) compared to a normative population. The lower the p value, the greater its clinical significance and the lesser likelihood of the defect having occurred “by chance”</li>
<li>Pattern deviation plot. This plot is similar to total deviation plot except that it is adjusted for any generalized depression, such as that caused by a cataract or miosis. Each test location is graded as normal, or abnormal at a defined level (p value) compared to a normative population. The lower the p value, the greater its clinical significance and the lesser likelihood of the defect having occurred “by chance”. Pattern deviation plot&#160;should be carefuly inspected for early detection or progression of glaucomatous visual filed loss.&#160;</li></ol>
<h4><span class="mw-headline" id="Summary_measures_of_visual_field_performance">Summary measures of visual field performance</span></h4>
<p>Several measures are provided as a summary of the visual field. These include:
</p>
<ol><li>Results of the glaucoma hemifield test (see <a href="#Identifying_Glaucomatous_VF_Loss_on_SAP">section 4.3</a>).</li>
<li>Visual field index (VFI). This index expresses the visual field status as a percent of a normal age-adjusted visual field. Greater weight is given to points closer to fixation to adjust for gangion cell density and visual function. The index may also be less sensitive to cataract and media changes.</li>
<li>Mean deviation (see <a href="#Identifying_Glaucomatous_VF_Loss_on_SAP">section 4.3</a>). The overall mean deviation is categorized as normal, or abnormal at a p-value of 5, 2, 1, or 0.5%, which lower p values corresponding with greater clinical significance and a lower likelihood that the result occurred by chance.</li>
<li>Pattern standard deviation (see <a href="#Identifying_Glaucomatous_VF_Loss_on_SAP">section 4.3</a>). The overall pattern standard deviation is categorized as normal, or abnormal at a p-value of 5, 2, 1, or 0.5%, which lower p values corresponding with greater clinical significance and a lower likelihood that the result occurred by chance.</li></ol>
<h2><span class="mw-headline" id="Establishing_reliability_of_results">Establishing reliability of results</span></h2>
<p>Several measures should be incorporated into an assessment of how reliable or meaningful the results of a single visual field test are:
</p>
<ol><li>Fixation losses. Fixation losses, identified as a result of positive responses to stimuli presented in the blind spot, suggest an unsteadiness of gaze which cloud the interpretation of the visual field test.</li>
<li>False positives. False positives occur when patient responses are noted in the absence of a presented stimulus. Patients with high false positive rates may show pale areas on the grey scale display, and abnormally high sensitivity on the glaucoma hemifield test.</li>
<li>False negatives.False negatives are identified when, upon retesting a previously tested location with a stimulus brighter than the measured threshold value, no response is detected.&#160; False negatives may be normal in eyes with advanced visual field loss, but typically reflect poor attention in eyes with little or no visual field damage.</li></ol>
<p><br />
High rates of fixation losses, false positive, or false negatives cloud the interpretation of visual field results in 2 ways. First, visual fields were not included into the normative database if rates of fixation losses, false positives or false negatives exceeded 33%.<sup id="cite_ref-Anderson2003_25-1" class="reference"><a href="#cite_note-Anderson2003-25">&#91;25&#93;</a></sup> Thus, clinical trials such as the Ocular Hypertension Treatment Study excluded these fields as unreliable, as statistical comparisons to normal may not be valid.<sup id="cite_ref-Keltner2007_28-0" class="reference"><a href="#cite_note-Keltner2007-28">&#91;28&#93;</a></sup> Second, visual fields with high rates of fixation losses, false positives or false negatives may indicate poor cooperation with testing procedures, which could yield inaccurate results.
</p>
<h2><span class="mw-headline" id="Identifying_Glaucomatous_VF_Loss_on_SAP">Identifying Glaucomatous VF Loss on SAP</span></h2>
<p>Visual field sensitivity to presented stimuli is noted for each test location. In the case of the Humphrey 24-2 testing algorithm, 54 individual points are tested, and the threshold value calculated for that point is compared to a database of normally-sighted individuals of similar age. Based on this comparison, the value for the threshold value at this location is classified as being normal, or abnormal at a 5%, 2%, 1% or 0.5% probability. Each individual location has a calculated deviation from the expected threshold value for a person of the same age and ethnicity. These individual point values are used to calculate the following summary statistics: 
</p>
<h3><span class="mw-headline" id="Mean_deviation">Mean deviation</span></h3>
<p>The average of these deviations across all test locations is referred to as the Mean Deviation (MD). Subjects, who are able to see dimmer stimuli than others of similar age and race will have positive values for their MD, while subjects who require brighter stimuli will have negative MD values. MD values for reliable tests typically range from +2 dB to -30 dB. 
</p>
<h3><span class="mw-headline" id="Pattern_Standard_Deviation">Pattern Standard Deviation</span></h3>
<p>Visual field loss in glaucoma is frequently non-uniform, and thus a measure which quantifies irregularities is desirable. Pattern standard deviation (PSD) measures irregularity by summing the absolute value of the difference between the threshold value for each point and the average visual field sensitivity at each point (equal to the normal value for each point + the MD). Visual fields with the age-normal sensitivity at each point will have a PSD of 0, as will visual fields in which each point is uniformly depressed from the age-normal value. Thus, the largest PSD will be registered for focal, deep visual field defects. Near-normal and severely damaged visual fields will both have low PSD. 
</p>
<h3><span id="Glaucoma_Hemifield_Test_(GHT)"></span><span class="mw-headline" id="Glaucoma_Hemifield_Test_.28GHT.29">Glaucoma Hemifield Test (GHT)</span></h3><p>
The GHT, devised for the Humphrey Field Analyzer, compares 24-2 visual fields into 10 regions,</p><div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:GHTRegions.JPG" class="image"><img alt="GHTRegions.JPG" src="/w/images/1/thumb/1/16/GHTRegions.JPG/300px-GHTRegions.JPG" decoding="async" width="300" height="306" class="thumbimage" srcset="/w/images/1/thumb/1/16/GHTRegions.JPG/450px-GHTRegions.JPG 1.5x, /w/images/1/1/16/GHTRegions.JPG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:GHTRegions.JPG" class="internal" title="Enlarge"></a></div></div></div></div><p> with 5 inferior regions representing mirror images of 5 corresponding superior regions. Differences between corresponding superior and inferior zones are compared with the differences present in the population of normal controls. Possible test outcomes are:<br />
</p><ul><li>Outside normal limits. The GHT is described as “outside normal limits” when differences between a matched pair of corresponding zones exceeds the difference found in 99% of the normal population, or when both members of a pair of zones are more abnormal than 99.5% of the individuals with the normative population.<sup id="cite_ref-Bosworth2000_29-0" class="reference"><a href="#cite_note-Bosworth2000-29">&#91;29&#93;</a></sup></li></ul>
<ul><li>Borderline. The GHT is described as borderline when matched pairs of zones are abnormal at the 97th percentile within the normative database</li></ul>
<ul><li>General reduction of sensitivity. VFs are described to have generalized reduction of sensitivity when both conditions for “outside normal limits” are not met, and the best region of the VF is depressed to a level at the 99.5th percentile within individuals of the normative database.</li></ul>
<ul><li>Abnormally high sensitivity. The GHT is described as having abnormally high sensitivity when the overall sensitivity in the&#160;affected &#160;region of the VF is better than 99.5% of individuals within the normative population.</li></ul>
<ul><li>Within normal limits. VFs are described as being within normal limits when none of the above conditions are met.</li></ul>
<p><br />
</p>
<table class="wikitable">
<tbody><tr>
<th>Patterns of Glaucomatous Visual Field Loss
</th></tr>
<tr>
<td>
<p>Generalized depression
</p><p>Paracentral scotoma
</p><p>Arcuate or Bjerrum scotoma
</p><p>Nasal Step
</p><p>Altitudinal Defect
</p><p>Temporal Wedge
</p><p>Central island
</p><p><b>VF defect must correlate with Optic nerve damage</b>
</p>
</td></tr></tbody></table>
<h2><span class="mw-headline" id="Common_perimetric_errors">Common perimetric errors</span></h2>
<p>Several types of errors can lead to inaccurate results: 
</p>
<ol><li>Incorrect patient name.</li>
<li>Incorrect patient age. As threshold values are compared to age-adjusted normal values, incorrect age entry will lead to comparisons with the wrong set of normal values.</li>
<li>Inappropriate correction of refractive error. Failure to properly correct for refractive error will cause stimuli to become visually defocused,</li>
<li>Lens rim artifacts. Thick rims for correcting refractive error, or inappropriate head positioning which causes the lens rim to block peripheral stimuli can cause artifactual depression of the peripheral points. Points are typically severely affected (often with threshold sensitivities of 0 dB), and often show an abrupt drop-off from directly adjacent points.</li>
<li>Cloverleaf fields. This pattern of visual field defects reflects poor visual attention and/or malingering. Field results typically show high rates of false negative responses.</li>
<li>Miotic pupils or Cataracts. Ocular features which allow less light to reach the retina can cause diffuse depression of the visual field, along with statistically significant decreases in mean deviation. A small pupil may simulate a glaucomatous visual field defect by generalized depression because of miosis or exacerbate an already constricted field, giving a false impression of progression of glaucoma.&#160; In cases with concomitant cataract, attention should be paid to the pattern deviation plot&#160; as it adjusts for generalized depression caused by the cataract.<br /></li></ol>
<h1><span class="mw-headline" id="Additional_Resources">Additional Resources</span></h1>
<ol><li>AAO, Basic and Clinical Science Course. Section 10: Glaucoma, 2015-2016.</li>
<li>Jampel HD, Singh K, Lin SC, Chen TC, Francis BA, Hodapp E, Samples JR, Smith SD. Assessment of visual function in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118:986-1002.</li></ol>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-Anderson1998-1"><span class="mw-cite-backlink"><a href="#cite_ref-Anderson1998_1-0">↑</a></span> <span class="reference-text">Anderson DR, Patella VM. Automated Static Perimetry. 2nd edition, St Louis, Mosby, 1998.</span>
</li>
<li id="cite_note-Hart1983-2"><span class="mw-cite-backlink"><a href="#cite_ref-Hart1983_2-0">↑</a></span> <span class="reference-text">Hart WM Jr, Burde RM. Three-dimensional topography of the central visual field. Sparing of foveal sensitivity in macular disease. Ophthalmol. 1983; 90(8):1028-38.</span>
</li>
<li id="cite_note-Armaly1969-3"><span class="mw-cite-backlink"><a href="#cite_ref-Armaly1969_3-0">↑</a></span> <span class="reference-text">Armaly MF. The size and location of the normal blind spot. Arch Ophthalmol. 1969; 81(2):192-201.</span>
</li>
<li id="cite_note-Kerrigan2000-4"><span class="mw-cite-backlink"><a href="#cite_ref-Kerrigan2000_4-0">↑</a></span> <span class="reference-text">Kerrigan-Baumrind LA, Quigley HA, Pease ME, et.al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41(3):741-8.</span>
</li>
<li id="cite_note-Leblanc1971-5"><span class="mw-cite-backlink"><a href="#cite_ref-Leblanc1971_5-0">↑</a></span> <span class="reference-text">LeBlanc EP, Becker B. Peripheral nasal field defects. Am J Ophthalmol 1971;72:415.</span>
</li>
<li id="cite_note-Werner1979-6"><span class="mw-cite-backlink"><a href="#cite_ref-Werner1979_6-0">↑</a></span> <span class="reference-text">Werner EB, Beraskow J. Peripheral nasal field defects in glaucoma. Ophthalmology 1979;86:1875.</span>
</li>
<li id="cite_note-Ballon1992-7"><span class="mw-cite-backlink"><a href="#cite_ref-Ballon1992_7-0">↑</a></span> <span class="reference-text">Ballon BJ, Echelman DA, Shields MB, et. al. Peripheral visual field testing in glaucoma by automated kinetic perimetry with the Humphrey Field Analyzer. Arch Ophthalmol. 1992;110(12):1730-2.</span>
</li>
<li id="cite_note-Johnson1987-8"><span class="mw-cite-backlink"><a href="#cite_ref-Johnson1987_8-0">↑</a></span> <span class="reference-text">Johnson CA, Keltner JL. Optimal rates of movement for kinetic perimetry. Arch Ophthalmol. 1987;105(1):73-5.</span>
</li>
<li id="cite_note-Allingham2004-9"><span class="mw-cite-backlink"><a href="#cite_ref-Allingham2004_9-0">↑</a></span> <span class="reference-text">Allingham RR, Freedman S, Damji K, Shafranov G. Shield's textbook of Glaucoma, 5th edition. Lippincott Williams &amp;amp;amp;amp;amp; Wilkins, 2004.</span>
</li>
<li id="cite_note-Greve1973-10"><span class="mw-cite-backlink"><a href="#cite_ref-Greve1973_10-0">↑</a></span> <span class="reference-text">Greve E: Single and multiple stimulus static perimetry in glaucoma: the two phases of perimetry. Doc Ophthalmol 1973;36:1-35.</span>
</li>
<li id="cite_note-Johnson1978-11"><span class="mw-cite-backlink"><a href="#cite_ref-Johnson1978_11-0">↑</a></span> <span class="reference-text">Johnson C, Keltner J, Balestrery F. Effects of target size and eccentricity on visual detection and resolution. Vision Res.fckLR1978;18:1217-1222.</span>
</li>
<li id="cite_note-Johnson1981-12"><span class="mw-cite-backlink"><a href="#cite_ref-Johnson1981_12-0">↑</a></span> <span class="reference-text">Johnson C, Keltner J, Balestrery F. Static and acuity profile perimetry at various adaptation levels. Doc Ophthalmol. 1981;50:371-388</span>
</li>
<li id="cite_note-Bengtsson1997-13"><span class="mw-cite-backlink"><a href="#cite_ref-Bengtsson1997_13-0">↑</a></span> <span class="reference-text">Bengtsson B, Olsson J, Heijl A, Rootzén H. A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmol Scand. 1997;75(4):368-75.</span>
</li>
<li id="cite_note-Bengtsson1998-14"><span class="mw-cite-backlink"><a href="#cite_ref-Bengtsson1998_14-0">↑</a></span> <span class="reference-text">Bengtsson B, Heijl A, Olsson J. Evaluation of a new threshold visual field strategy, SITA, in normal subjects. Swedish Interactive Thresholding Algorithm. Acta Ophthalmol Scand. 1998;76(2):165-9.</span>
</li>
<li id="cite_note-Shirato1999-15"><span class="mw-cite-backlink"><a href="#cite_ref-Shirato1999_15-0">↑</a></span> <span class="reference-text">Shirato S, Inoue R, Fukushima K, Suzuki Y. Clinical evaluation of SITA: a new family of perimetric testing strategies. Graefes Arch Clin Exp Ophthalmol. 1999;237(1):29-34.</span>
</li>
<li id="cite_note-Sharma2000-16"><span class="mw-cite-backlink"><a href="#cite_ref-Sharma2000_16-0">↑</a></span> <span class="reference-text">Sharma AK, Goldberg I, Graham SL, Mohsin M. Comparison of the Humphrey swedish interactive thresholding algorithm (SITA) and full threshold strategies. J Glaucoma 2000;9(1):20-7.</span>
</li>
<li id="cite_note-Sekhar2000-17"><span class="mw-cite-backlink"><a href="#cite_ref-Sekhar2000_17-0">↑</a></span> <span class="reference-text">Sekhar GC, Naduvilath TJ, Lakkai M, et, al. Sensitivity of Swedish interactive threshold algorithm compared with standard full threshold algorithm in Humphrey visual field testing. Ophthalmology 2000;107(7):1303-8.</span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><a href="#cite_ref-18">↑</a></span> <span class="reference-text">Heijl A, Patella VM, Chong LX, et al. A New SITA perimetric threshold testing algorithm: construction and a multicenter clinical study. Am J Ophthalmol. 2019;198:154-165.</span>
</li>
<li id="cite_note-Esterman1982-19"><span class="mw-cite-backlink"><a href="#cite_ref-Esterman1982_19-0">↑</a></span> <span class="reference-text">Esterman B. Functional scoring of the binocular field. Ophthalmology 1982;89(11):1226-34.</span>
</li>
<li id="cite_note-Ramulu2009-20"><span class="mw-cite-backlink"><a href="#cite_ref-Ramulu2009_20-0">↑</a></span> <span class="reference-text">Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009;20(2):92-8.</span>
</li>
<li id="cite_note-Quigley1988-21"><span class="mw-cite-backlink"><a href="#cite_ref-Quigley1988_21-0">↑</a></span> <span class="reference-text">Quigley HA, Dunkelberger, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology 1988;95:357-363.</span>
</li>
<li id="cite_note-Johnson1993-22"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Johnson1993_22-0">22.0</a></sup> <sup><a href="#cite_ref-Johnson1993_22-1">22.1</a></sup></span> <span class="reference-text">Johnson CA, Adams AJ, Casson EJ, et al. Progression of early glaucomatous visual field loss for blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol 1993;111:651-656.</span>
</li>
<li id="cite_note-Johnson1997-23"><span class="mw-cite-backlink"><a href="#cite_ref-Johnson1997_23-0">↑</a></span> <span class="reference-text">Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency- doubling perimetry. Invest Ophthalmol Vis Sci 1997; 38:413-425.</span>
</li>
<li id="cite_note-Demirel2001-24"><span class="mw-cite-backlink"><a href="#cite_ref-Demirel2001_24-0">↑</a></span> <span class="reference-text">Demirel S, Johnson CA. Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol 2001;131:709-715.</span>
</li>
<li id="cite_note-Anderson2003-25"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Anderson2003_25-0">25.0</a></sup> <sup><a href="#cite_ref-Anderson2003_25-1">25.1</a></sup></span> <span class="reference-text">Anderson AJ, Johnson CA. Frequency-doubling technology perimetry. Ophthalmol Clin N Am 2003;16:213-225.</span>
</li>
<li id="cite_note-Cioffi2000-26"><span class="mw-cite-backlink"><a href="#cite_ref-Cioffi2000_26-0">↑</a></span> <span class="reference-text">Cioffi GA, Mansberger S, Spry P, et al. Frequency doubling perimetry and the detection of eye disease in the community. Tr. Am. Ophth. Soc. 2000;98:195-202.</span>
</li>
<li id="cite_note-Spry2001-27"><span class="mw-cite-backlink"><a href="#cite_ref-Spry2001_27-0">↑</a></span> <span class="reference-text">Spry PGD, Johnson CA, McKendrick AM, et al. Variability components of standard automated perimetry and frequency doubling technology perimetry. Invest Ophthalmol Vis Sci 2001;42:1404-1410.</span>
</li>
<li id="cite_note-Keltner2007-28"><span class="mw-cite-backlink"><a href="#cite_ref-Keltner2007_28-0">↑</a></span> <span class="reference-text">Keltner JL, Johnson CA, Cello KE, et. al. Visual field quality control in the Ocular Hypertension Treatment Study (OHTS). fckLRJ Glaucoma. 2007 Dec;16(8):665-9.</span>
</li>
<li id="cite_note-Bosworth2000-29"><span class="mw-cite-backlink"><a href="#cite_ref-Bosworth2000_29-0">↑</a></span> <span class="reference-text">Bosworth CF, Sample PA, Johnson CA, Weinreb RN. Current practice with standard automated perimetry. Semin Ophthalmol. 2000;15(4):172-81.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035202
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.191 seconds
Real time usage: 1.421 seconds
Preprocessor visited node count: 839/1000000
Post‐expand include size: 5889/2097152 bytes
Template argument size: 1240/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 12513/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  737.454      1 Template:Article
100.00%  737.454      1 -total
 85.11%  627.673      4 Template:Infobox_section
 49.00%  361.346      8 Template:UserLookup
  4.52%   33.347      1 Template:Infobox_begin
  0.83%    6.098      1 Template:Get_active_contest
  0.61%    4.463      1 Template:Review_expired
  0.12%    0.909      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Standard_Automated_Perimetry&amp;oldid=87693">https://eyewiki.org/w/index.php?title=Standard_Automated_Perimetry&amp;oldid=87693</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzyzzbfj">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Standard_Automated_Perimetry" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Standard_Automated_Perimetry" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Standard_Automated_Perimetry&amp;oldid=87693" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Standard_Automated_Perimetry&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 25, 2022, at 17:01.</div>
					<div>This page has been accessed 619,910 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.191","walltime":"1.421","ppvisitednodes":{"value":839,"limit":1000000},"postexpandincludesize":{"value":5889,"limit":2097152},"templateargumentsize":{"value":1240,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":12513,"limit":5000000},"timingprofile":["100.00%  737.454      1 Template:Article","100.00%  737.454      1 -total"," 85.11%  627.673      4 Template:Infobox_section"," 49.00%  361.346      8 Template:UserLookup","  4.52%   33.347      1 Template:Infobox_begin","  0.83%    6.098      1 Template:Get_active_contest","  0.61%    4.463      1 Template:Review_expired","  0.12%    0.909      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035202","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":2047});});</script></body>
</html>